1. Introduction {#sec1}
===============

Obesity is a major global public health challenge associated with increased incidence of diabetes, metabolic syndrome, heart disease and other health issues \[[@bib1]\]. In developed countries, two in three adults are overweight \[[@bib2]\] while almost one in two adults is physically inactive \[[@bib3]\]. It is well documented that lifestyle factors, i.e. lack of physical activity (PA) and poor nutrition, are the main drivers of obesity \[[@bib4]\]. Exercise training is a crucial preventive and treatment anti-obesity strategy \[[@bib5]\]. Weight loss programs using exercise usually target a modest (5--10%) reduction in body mass by promoting caloric expenditure over intake. Although, this rate may not normalize the weight of an obese individual, it will lower, however, the cardiometabolic risk \[[@bib6], [@bib7]\].

Obese adults have low cardiorespiratory fitness (CRF) that augments cardiometabolic risk and lowers functional capacity \[[@bib5], [@bib8]\]. Exercise guidelines for overweight/obese adults recommend the inclusion of cardiovascular, resistance, and flexibility training ideally targeting to 300--420 min/week aiming to improve all components of physical fitness \[[@bib9], [@bib10]\]. Continuous endurance training (CET), resistance exercise training (RT), high-intensity interval training (HIIT) are the main exercise modes used for effective weight management, improvement of skeletal muscle metabolism, increase of resting metabolic rate (RMR), physical performance, functional capacity, body composition and lowering of risk factors associated with obesity such as insulin resistance and lipid profile \[[@bib11]\].

A major drawback of traditional training modalities, i.e. CET and RT, is their high attrition and low adherence rates when applied in previously inactive obese adults \[[@bib12]\]. Lack of time is one of the most common personal barriers for exercise participation in adults \[[@bib13]\]. Non-traditional, HIIT training protocols have recently become more popular among adults and improve health and physical performance in a more time-efficient manner \[[@bib14], [@bib15], [@bib16], [@bib17]\]. HIIT protocols appear to be equally effective in increasing CRF as traditional moderate-intensity CET protocols in adults with chronic cardiometabolic lifestyle diseases \[[@bib18],[@bib19]\]. A limited number of studies revealed that 9-week \[[@bib20]\] and 16-week \[[@bib21],[@bib22]\] HIIT interventions can induce neuromuscular and metabolic adaptations in healthy untrained or recreationally active adults. Moreover, training programs that incorporate movements mimicking the activities of daily living challenge the neuromuscular system which is crucial for adults with impaired neuromuscular function as the obese \[[@bib23]\].

We have recently shown \[[@bib15]\] that an injury-free, HIIT-type protocol that incorporates integrated neuromuscular training (the DoIT protocol) using whole-body movements with alternative portable exercise equipment \[[@bib24],[@bib25]\] and performed in a real-world setting, can provoke a considerably body mass and fat loss, increase RMR, strength and CRF in previously inactive overweight/obese women. Here we describe the proposed rationale, design, and methodology for a randomized clinical trial aiming to determine the dose-response effects of DoIT on body mass, body composition, health, performance and quality of life in sedentary male and female obese adults during a 1-year supervised training intervention. The results of this study will expand our understanding regarding the optimal volume and frequency of such protocols for promoting sustainable weight loss, favorable health adaptations, increased functionality and quality of daily life in otherwise-healthy, inactive, overweight/obese adults.

2. Methods {#sec2}
==========

2.1. Overview {#sec2.1}
-------------

The methods, procedures, and ethics of the present study have been examined and approved by the Institutional Ethics Committee (ref. number 1386/6-6-2018). Procedures are in agreement with the 1975 Declaration of Helsinki as revised in 2000 and all data obtained will be confidential and only the researchers of the study will have access to database. The present study has been registered on the ClinicalTrials.gov website under the registry number NCT03759951.

2.2. Participant characteristics and eligibility {#sec2.2}
------------------------------------------------

Participants will be contacted using advert fliers posted in the local community, social media and by word of mouth. Participants should meet the following inclusion criteria: a) inactivity (no participation in an exercise or PA program for ≥6 months prior to the study, a VO~2~max \<30 ml·kg-1·min-1, \<7,500 steps/day, and \<30 min/day of moderate-to-vigorous PA based on accelerometry); b) age of 30--50 years; c) overweight or obese class 1 (BMI 25.0--34.9), d) body fat percentage ≥32% for women and ≥25% for men; d) medical clearance for strenuous exercise; e) no smoking for ≥6 months before the study; f) no diet intervention or usage of nutritional supplements/medications before (≥6 months) and during the study; g) no weight loss greater \>10% of body mass before (≤6 months) the study; and h) no diagnosis or symptoms of cardiovascular, metabolic, pulmonary, renal, musculoskeletal or mental disorders. Moreover, participants will be excluded from the study if they: a) did not participate in ≥80% of total exercise sessions, b) adhered to a nutritional intervention, and c) modified their habitual PA levels during the study.

2.3. Study design {#sec2.3}
-----------------

DoIT is a controlled, randomized, repeated-measures, 4-group, clinical trial. [Fig. 1](#fig1){ref-type="fig"} shows the flow diagram of the study. Initially, participants will have their body mass and height, resting metabolic rate (RMR), habitual daily PA, and daily nutritional intake measured. Thereafter, a 4-week adaptive period will be implemented during which participants will adapt to an isocaloric diet (that will be designed by a trained clinical dietician), based on each participant\'s dietary analysis, daily PA and RMR. A dietitian will provide participants with instructions on how to adapt to a weight maintenance diet (55--60% carbohydrate, 15--20% protein, 20%--25% fat) during the adaptive period. The diet plan will be re-adjusted every three months to verify the accuracy of the assigned energy approach. During the adaptive period, participants will also be familiarized with exercises techniques and overload patterns that will be used throughout the 1-year study. At the end of the adaptive period, volunteers will undergo baseline testing (habitual PA, caloric intake, RMR, somatometrics, body composition, physical fitness, health biomarkers and quality of life) at University facilities.Fig. 1Consolidated Standards of Reporting Trial (CONSORT) guidelines flow diagram of the DoIT study.Fig. 1

Following baseline testing, participants will be randomly assigned to the four groups: (i) a control group (C) during which no intervention will be implemented (only measurements will be performed); (ii) an exercise training group with one exercise session/week (DoIT-1); (iii) an exercise training group with two exercise sessions/week (DoIT-2); and (iv) an exercise training group with three exercise sessions/week (DoIT-3). All groups will be followed over a period of 12 months. Randomization will be achieved using a random-numbers table (allocation sequence conducted by an independent researcher and will be concealed until interventions will be assigned). A member of the research team will enroll and assign participants to interventions. Baseline testing will be repeated after 6 months (mid-training testing) and 12 months (post-training testing) of intervention at University facilities within 5 days after the completion of the last training session each time. [Fig. 2](#fig2){ref-type="fig"} illustrates the experimental flowchart.Fig. 2The experimental flowchart.Fig. 2

C, control group; DoIT-1, training group (1 session/week); DoIT-2, training group (2 sessions/week); DoIT-3, training group (3 sessions/week); DXA, dual energy X-ray absorptiometry; RMR, resting metabolic rate; HR, heart rate; RPE, rate of perceived exertion; ^1^for all groups (4-week adaptive period); ^2^only for DoIT-1, DoIT-2 and DoIT-3; ^3^for all groups.

2.4. Exercise intervention {#sec2.4}
--------------------------

A supervised exercise training protocol will be performed one (DoIT-1), two (DoIT-2) or three (DoIT-3) times/week for 12 consecutive months. All sessions will use an asynchronous music playing in the background and with no instruction to participants to perform exercises in synchronization with musical tempo \[[@bib28]\]. The training protocol will be characterized by progression in both exercise intensity and volume. The exercises selection and work-to-rest ratio will be varied depending on the response of participants every 4 weeks. Specifically, the exercise will consist of 8--12 neuromotor exercise stations in circuit fashion (1--3 rounds) using a prescribed time of effort and passive recovery intervals according to specific work-to-rest ratios. The total length of each session will be less than 30 min excluding warm-up and cool down periods. Participants performed as many repetitions as possible at each station with proper form at a controlled, moderate speed.

All prescribed exercises will incorporate multi-planar, fundamental and complex movements (squat, hinge, lunge, push, pull, carry, rotation, and plank) using bodyweight \[[@bib23],[@bib25]\] or adjunct portable modalities (suspension belts, balance balls, kettlebells, medicine balls, battle ropes, stability balls, speed ladders, foam rollers, and elastic bands) as resistance \[[@bib29]\]. A 10-min warm-up with low-intensity cardiovascular exercise, dynamic stretching and movement preparation drills and a 5-min cool-down period of very low-intensity cardiovascular exercise and static stretching will be included in each session. Participants will be instructed to execute as many repetitions as possible at each exercise station with proper form. Each session will be consisted of alternate stations emphasizing on health- and motor-related fitness parameters including cardiovascular, resistance and neuromotor drills. To maintain a high-intensity stimulus, i.e. ≥60% of reserve oxygen consumption (VO~2~R), throughout each session according to the guidelines for exercise prescription in previously inactive obese adults \[[@bib9]\], verbal encouragement will be provided to participants. The rate of perceived exertion (RPE) will be recorded at the end of each round and heart rate (Polar Team Solution, Polar Electro-Oy, Kempele, Finland) will be monitored throughout each session. Mean and maximal heart rates will be recorded and mean RPE will be calculated for each session. To maximize adherence, each session will have a maximum of 5--8 participants training simultaneously. [Table 1](#tbl1){ref-type="table"} illustrates the configuration of the training protocol throughout the 1-year intervention.Table 1The characteristics of the exercise protocol throughout the 1-year intervention.Table 1Training ParametersMonthsYearly Mean123456789101112Session duration (min)13.515.720.730.333.333.536.539.533.836.834.037.030.4Net exercise time (min)[a](#tbl1fna){ref-type="table-fn"}3.04.78.311.312.515.016.518.019.321.022.024.014.6Recovery time (min)[b](#tbl1fnb){ref-type="table-fn"}10.511.012.319.020.818.520.021.514.515.812.013.015.7Work-to-rest ratio1:31:21:21:1.41:1.41:11:11:11.4:11.4:12:12:11:1.1Work interval (sec)15.020.020.025.025.030.030.030.035.035.040.040.028.8Rest interval (sec)45.040.040.035.035.030.030.030.025.025.020.020.031.3Number of exercises6789101011121112111210Rounds1--2223333333333Rest time/round (min)3.03.03.02.52.52.52.52.52.02.02.02.02.5Movement number[c](#tbl1fnc){ref-type="table-fn"}Max.Max.Max.Max.Max.Max.Max.Max.Max.Max.Max.Max.Max.[^1][^2][^3]

2.5. Measurements {#sec2.5}
-----------------

### 2.5.1. Descriptor variables {#sec2.5.1}

#### 2.5.1.1. Habitual physical activity measurements {#sec2.5.1.1.}

Participants will be encouraged to maintain their usual daily PA throughout the study. Accelerometry (GT3X+, ActiGraph, Pensacola, FL, USA) will be used to determine habitual PA level every 3 months over a 7-day period as described \[[@bib30]\]. Researchers will instruct participants on how to use the accelerometer, which will be placed into adjustable belts and will be over the right hip during the measurement apart from bathing, swimming and sleep. Collected data will be included in the analysis, if participants will have ≥4 days and ≥10 wear hours/day \[[@bib31]\]. Non-wear time will be calculated \[[@bib32]\] and daily activity levels and sedentary time will be expressed as steps per day and time spent at sedentary, light, moderate, vigorous, and moderate-to-vigorous PA \[[@bib33]\]. ActiLife 6 software will be used for initializing the accelerometers and downloading data using a 60-s epoch length.

#### 2.5.1.2. Dietary assessment {#sec2.5.1.2.}

Caloric intake will be measured using 7-day diet recalls every three months to confirm the precision of the allocated energy approach. A clinical dietitian will train participants how to record food/fluid consumption. Participants will be asked to not modify their dietary behavior throughout the study. Diet recalls will be analyzed for energy and macronutrient intake using a nutrition analysis software (Science Fit Diet 200A, Science Technologies, Athens, Greece).

#### 2.5.1.3. Exercise energy expenditure {#sec2.5.1.3.}

will be measured in only 50% participants of each exercise group (randomly selected at baseline) due to time constraints. Exercise energy cost and excess post-exercise oxygen consumption (EPOC) will be measured using portable indirect calorimetry (VmaxST, Sensormedics, Yorba Linda, CA) as described \[[@bib15],[@bib36]\]. Total energy expenditure of an exercise session will be estimated by summing a) the aerobic energy expenditure during exercise which will be estimated using a constant value of 21.14 kJ (5.05 kcal/)/liter oxygen \[[@bib15],[@bib38]\], b) the anaerobic energy expenditure using resting and post-exercise blood lactate concentration measurements \[[@bib15],[@bib39]\], and c) excess post-exercise oxygen consumption. Blood lactate will be measured using blood samples that will be collected pre-, mid- and post-exercise session (3 min post-exercise). In order to avoid any potential contamination due to interference with sweat, researchers will collect the blood sample after they will have thoroughly cleaned, disinfected and dried subjects\' whole hands and the single finger that will be used for blood sampling. Thereafter, a lancet will be used to puncture participants' skin at the finger, the first blood drop will be directed on the measurement strip and the blood lactate concentration will be analyzed using a hand-portable analyzer (Accutrend Plus, Roche Diagnostics, Switzerland) within a few seconds following collection \[[@bib15]\].

### 2.5.2. Primary outcome measures {#sec2.5.2}

#### 2.5.2.1. Somatometric measures {#sec2.5.2.1}

Somatometric measurements will be conducted at pre-, mid-, and post-training. Height and body mass will be measured to the nearest 0.1 cm and 0.1 kg, respectively, using a beam scale (Beam Balance-Stadiometer, SECA, Vogel & Halke, Hamburg, Germany) and body mass index (BMI) will be calculated as weight per height squared. Waist (WC) and hip circumferences (HC) will be measured three times using a Gullick II, the mean will be recorded while the waist-to-hip ratio (WHR) will be calculated \[[@bib34]\]. Total and regional fat mass (FM), fat-free mass (FFM), bone mineral content (BMC) and bone density (BMD) will be determined utilizing a dual energy X-ray absorptiometry (DXA) scanner (GE Healthcare, Lunar DPX-NT) according to standard procedures as previously described \[[@bib35]\]. DXA measurements will be performed pre- and post-training. The effective radiation dose will be \< 0.3 mSv per whole-body scan. All analyses will be performed using the 12.2 GE enCORE software package.

#### 2.5.2.2. Physical fitness measures {#sec2.5.2.2}

All physical fitness assessments will be conducted pre-, mid-, and post-training. CRF will be assessed using a low-risk, low-cost and single-stage submaximal treadmill walking test (Stex 8025T, South Korea) for estimating peak oxygen uptake (VO~2peak~). This test is considered a suitable for previously inactive, apparently healthy, and non-athletic adults with potential physical limitations \[[@bib40]\]. According to the protocol, the walking speed for the test will be individually determined based on participant\'s gender, age, and fitness level using standard procedures \[[@bib41]\].

Bilateral maximal isotonic strength (one repetition maximal, 1RM) will be assessed using standard procedures for novice and untrained individuals \[[@bib42]\] in four upper body (seated chest press, lat pull-down, vertical row, seated shoulder press) and three lower body (horizontal leg press, lying leg curls, seated leg extension) exercises positioned on strength training equipment (Panatta Sport, Apiro, Italy). All 1RM tests will be performed following familiarization \[[@bib42]\]. All attempts will be performed with no rest until muscle failure while verbal encouragement will be given to the participant. Muscular endurance will be assessed using timed tests for the abdominal (partial curl-ups), upper- (traditional push-ups for males and modified kneeling push-ups for females) and lower-body (modified chair squat) musculature. All tests require the participants to perform as many repetitions as possible within 60 s using standard procedures \[[@bib42]\].

The modified sit-and-reach test was used to assess the flexibility of lower back and hamstrings and goniometry (Lafayette 01135 Gollehon Extendable Goniometer, Lafayette Instrument Inc., Lafayette, IN, USA) to measure the range of motion (ROM) of the ankles, knees, hips, elbows, and shoulders as previously described \[[@bib43]\]. Static balance will be assessed using the modified Romberg test as previously described \[[@bib44]\]. Functional mobility, postural stability and movement behavior in different settings without locomotion will be evaluated using a quick, noninvasive, low-cost and movement-based screening tool called Functional Movement Screening (FMS). The FMS will attempt to assess seven movement tasks that each will be scored from 0 to 3 points (0 = pain with pattern regardless of quality, 1 = unable to perform pattern, 2 = able to perform pattern with compensation/imperfection, 3 = able to perform pattern as directed) and their sum will provide the total score ranging from 0 to 21 points. The FMS is considered a simple and quantifiable method of evaluating basic movement abilities while identifying muscle imbalances and asymmetries during physical exercise and ADL \[[@bib45]\].

#### 2.5.2.3. Physiological measures {#sec2.5.2.3}

Resting metabolic rate measurement (RMR) will be assessed pre-, mid, and post-training using resting VO~2~/CO~2~ measurements in the morning (07.00--09.00) after an overnight fast utilizing an open-circuit indirect calorimeter with a ventilated hood system (Vmax Encore 29, BEBJO296, Yorba Linda, CA, USA) as described \[[@bib36]\] and the 24-h RMR will be calculated using the Weir equation \[[@bib37]\]. RMR assessments will be performed in only 50% participants of each group (randomly selected at baseline) due to time constraints.

#### 2.5.2.4. Measures of wellbeing {#sec2.5.2.4}

Health-related quality of life (HRQoL) will be assessed pre-, mid-, and post-training using the physical and mental component subscales of the Greek 36-Item Short-Form Health Survey (SF-36), which has been shown to be valid and reliable \[[@bib46]\]. The SF-36 consists of eight subscales (vitality, physical functioning, bodily pain, general health perceptions, physical role functioning, emotional role functioning, social role functioning, and mental health) and its scores on both component subscales of the SF-36 will range from 0 to 100, with higher scores indicating better health status while the minimal clinically important difference will be 2 points. Exercise enjoyment will be assessed using the Exercise Enjoyment Scale (EES), which is a single-item 7-point scale to assess enjoyment pre-, during, and post-exercise ranging from "not at all" at 1 to "extremely" at 7 \[[@bib47]\].

#### 2.5.2.5. Biochemical measures {#sec2.5.2.5}

Resting blood samples will be collected pre- and post-training at 07:00--09:00 a.m. following an overnight fasting (10--12 h). Participants will be abstained from any type of strenuous physical activity or structured exercise for the last 72 h before testing. A physician will collect all blood samples. Venous blood samples (∼10 mL) will be drawn at a seated position from the antecubital arm vein by venipuncture with a 20-gauge disposable needle equipped with a Vacutainer tube holder (Becton Dickinson, Franklin Lakes, NJ, USA). Blood will be collected in tubes containing ethylenediaminetetraacetic acid (EDTA) or SST-Gel/clot activator for plasma and serum preparation, respectively. Plasma or serum will be obtained by centrifugation (1370 g, 4 °C, 10 min for plasma separation; 1500 g, 4 °C, 15 min for serum separation). For serum separation, blood will be allowed to clot at room temperature first. Serum and plasma samples will be stored in multiple aliquots at −80 °C until assayed (in duplicate).

##### 2.5.2.5.1. Cardiometabolic measures {#sec2.5.2.5.1}

Serum leptin will be determined by using a commercially available ELISA kit and plasma adiponectin will be analyzed by using a commercially available RIA (Linco Research, Inc., St. Charles, MO, USA) \[[@bib36]\]. Serum cortisol will be measured using an electrochemiluminescence immunoassay (ECLIA) (Cobas e 411 Analyzer, Roche Diagnostics GmbH, Mannheim, Germany). Serum insulin will be measured photometrically with an immunoassay and plasma glucose will be determined spectrophotometrically using the glucose oxidase method \[[@bib36]\]. The homeostatic model assessment for insulin resistance (HOMA-IR) will be calculated according to the equation: glucose (mM) X insulin (μIU/ml)/22,5 \[[@bib49]\]. Triglycerides (TG), total cholesterol (TC) and high-density lipoprotein cholesterol (HDL) will be measured photometrically using a biochemical analyzer \[[@bib50]\]. Low-density lipoprotein (LDL) cholesterol will be calculated using the Friedwald equation \[[@bib51]\]. Atherogenic index will be calculated as TC/HDL.

##### 2.5.2.5.2. Inflammatory measures {#sec2.5.2.5.2}

C-reactive protein (CRP) will be measured as an inflammatory marker with a clinical chemistry analyzer \[[@bib52]\]. Reduced glutathione (GSH), oxidized glutathione (GSSG), thiobarbituric acid-reactive substances (TBARS), protein carbonyls (PC), and catalase activity (CAT) in erythrocyte lysates, serum total antioxidant capacity (TAC), and catalase activity (CAT) will be analyzed spectrophotometrically as previously described \[[@bib53]\].

##### 2.5.2.5.3. Measures of appetite regulation {#sec2.5.2.5.3}

Possible changes in appetite-regulating hormones including cholecystokinin (CKK), pancreatic polypeptide (PP), peptide YY (PYY), oxyntomodulin (OXM), ghrelin and glucagon-like peptide-1 (GLP-1) will be measured as previously described \[[@bib54]\]. Changes in appetite will be assessed pre-, mid, and post-training using the Visual Analog Scale (VAS) to measure perceived hunger, satiety, and individual\'s own interpretation of their hunger sensations. VAS is a straight horizontal line of fixed length, usually 100 mm. The ends are defined as the extreme limits of the parameter to be measured orientated from the left (worst) to the right (best) \[[@bib48]\].

2.6. Statistical analyses {#sec2.6}
-------------------------

A Kolmogorov-Smirnov analysis will be used to determine data normality. Parametric statistics will be applied if data is normally distributed. Initially, a one-way ANOVA will be utilized for baseline comparisons of the four groups on all primary outcome variables. Based on study\'s design, the primary independent endpoints are the treatment groups (four groups based on training frequency) time (three time points, i.e. baseline, mid-training, post-training). To examine the interaction between the independent endpoints, a two-way ANOVA repeated measures will be applied on each primary outcome measure. If an interaction exists, the simple effect and pairwise comparisons will be used to detect differences between groups at each time point. If no interaction exists, an analysis for main effect on each independent factor will be performed. If a main effect is detected, a post-hoc analysis (Bonferroni) will be performed to detect the differences between groups or repeated measures for each primary outcome. If data will not be normally distributed, non-parametric tests will be applied. Baseline comparisons will be performed using the Kruskal--Wallis test. Time-effects in each trial will be determined using the Friedman test followed by the Wilcoxon signed-rank test for pairwise comparisons. Between trials differences will be examined via the Kruskal--Wallis test followed by the Mann-Whitney test for pairwise comparisons. Statistical significance will be accepted at p \< 0.05. Effect sizes (ES) and confidence intervals (CI) will be calculated on results of all dependent variables using the Hedge\'s g method, corrected for bias. ES will be interpreted as none, small, medium-sized, and large for values 0.00--0.19, 0.20--0.49, 0.50--0.79, and ≥0.8, respectively.

The G\*Power program (G\*Power 3.1.9.2) was utilized to perform power analysis \[[@bib26]\] to calculate the sample size needed for the interaction between the independent endpoints (four groups and three measurements points) and main effects for group or time in the main dependent endpoint measures (body mass, body fat mass, lean body mass) using an effect size of \>0.55, a probability error of 0.05, and a two-tailed alpha level and power of 0.80. The results indicated that a number of 16 participants/group is needed to detect meaningful interaction between endpoints, 12 for main effect on the independent endpoint time and 16 for main effect on the independent endpoint group. Accepting a potential drop-out rate of 20% and using the formula: n' = n/(1-p) \[[@bib27]\], it was estimated that the number of participants to be recruited would be 12.8--20 per group. Therefore, a number of 22 participants/group will be recruited, resulting in a total sample size of 88.

3. Discussion {#sec3}
=============

Approximately one in three adults demonstrates insufficient physical activity \[[@bib3]\] and more than one in two adults are overweight or obese worldwide \[[@bib2]\]. It has been estimated that the global cost of obesity-related illness is truly alarming, and therefore, evidence-based and cost-effective treatments are high priorities for the public healthcare systems worldwide \[[@bib55]\]. Extensive research findings support the positive impact of organized exercise in morbidity and mortality rates of the sedentary obese adult population \[[@bib56],[@bib57]\]. Exercise alone can be a beneficial strategy for reducing obesity-related medical risks by improving a variety of risk factors that systematically decrease life expectancy and quality of life \[[@bib9]\]. Lack of time \[[@bib13]\], pleasure, enjoyment and adherence have been reported as key factors for preventing exercise engagement in obese adults \[[@bib58]\].

Several investigations have been conducted to induce cardiovascular, neuromuscular and metabolic adaptations while improving well-being and enhancing health benefits through traditional and nontraditional exercise programs among obese adults \[[@bib20],[@bib26]\]. Although CET, RT, HIIT, and various combinations of these exercise modalities appear to provoke weight and fat loss and improve performance in untrained, obese adults \[[@bib11]\], the majority of studies in this field were of limited length of time, used traditional exercise protocols and demonstrated low adherence and high attrition rates \[[@bib12],[@bib13]\]. Emerging research supports that HIIT-type exercise protocols elicit beneficial cardiometabolic adaptations in both healthy and clinical populations as CET but with a shorter time commitment \[[@bib59],[@bib60]\]. Recently published data demonstrate that HIIT in the real world can be applied as an appropriate exercise training option for overweight or obese individuals \[[@bib61]\]. However, unsupervised 12-month HIIT exhibited a low adherence rate in overweight or obese adults \[[@bib61]\]. On the other hand, RT offers positive neuromuscular adaptations and health benefits when applied in type 2 diabetes and overweight/obese adults with metabolic syndrome and increased cardiovascular disease risk factors \[[@bib62],[@bib63]\].

Recently, implementation of a new of HIIT-type, integrated neuromuscular training modality that uses resistance exercises that incorporate whole-body movements in overweight/obese adult women, induced a ∼6% loss of body mass and fat (∼0.6% loss per month), which was associated with an increase of fat free mass (∼3.5%), RMR (∼10%), strength (∼22%), and CRF (∼24%) \[[@bib15]\]. These beneficial adaptations were obtained using a metabolic overload of only 5--12 MET-hours/week and total exercise time/week of ∼100 min/week \[[@bib15]\]. These training-induced gains were not attenuated by a 5-month detraining \[[@bib15]\]. Furthermore, this program demonstrated a high adherence rate (94%) \[[@bib15]\] corroborating reports suggesting that nontraditional, HIIT-type training modalities using bodyweight resistance exercises and alternative resistance equipment using movements that mimic everyday life movement patterns are very attractive and popular \[[@bib14],[@bib64],[@bib65]\]. This is the first longitudinal study that attempts to assess the dose-response effects of this HIIT-type, integrated neuromuscular training on body mass, energy balance, health status, performance and well-being of inactive overweight/obese adults.

Current guidelines for weight loss developed by respected organizations such as the World Health Organization suggest organized PA of at least 150 min/week. HIIT-type protocols seem to be more time efficient, inducing considerable health gains in shorter time \[[@bib9],[@bib11],[@bib15]\]. The DoIT protocol requires a total session duration of less than 30 min while the net exercise time being less than 15 min/session \[[@bib15]\]. This trial will not only determine the efficacy of HIIT-type, integrated neuromuscular training on weight and fat loss of inactive overweight/obese adults of both sexes but it will allow us to understand the optimal workload and frequency associated with beneficial changes in health and quality of life of this cohort. Results of this study will provide insight in our effort to provide more accurate exercise guidelines for HIIT-type protocols by identifying the frequency threshold capable of promoting sustained body mass and fat loss, health gains and changes in the quality of life in a high-risk population.

4. Conclusions {#sec4}
==============

The DoIT trial is the first randomized controlled trial that investigates in-depth the long-term efficacy and the dose-response effects on health, performance and quality of life of a new HIIT-type exercise intervention incorporating integrated neuromuscular, whole-body resistance exercises in sedentary, obese adults of both sexes. Results of this study will provide more detailed data associated with a novel, supervised and time-efficient exercise protocol in order to be considered as an evidence-based and applicable anti-obesity strategy in the real world. Results will aid the formulation of more solid guidelines of exercise prescription for the implementation of this type of protocols in previously inactive overweight/obese adults. Specifically, the outcomes of this study will provide information about the optimal volume and frequency associated with favorable changes in body mass, body composition, daily energy balance, health, performance, and quality of life of overweight/obese adults.
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The following is the Supplementary data to this article:Multimedia component 1Multimedia component 1

Supplementary data to this article can be found online at <https://doi.org/10.1016/j.conctc.2019.100386>.

[^1]: Effort time is session duration minus recovery time.

[^2]: Recovery time is session duration minus effort time.

[^3]: maximal number of repetitions/station.
